{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:59:26Z","timestamp":1792407566358,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12366312"],"award-info":[{"award-number":["GR-2018-12366312"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2018-12365425"],"award-info":[{"award-number":["RF-2018-12365425"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-23068"],"award-info":[{"award-number":["IG-23068"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-23643"],"award-info":[{"award-number":["IG-23643"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      About 50% of cutaneous melanoma (CM) harbors the activating BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      mutation which exerts most of the oncogenic effects through the MAPK signaling pathway. In the last years, a number of MAPK modulators have been identified, including Spry1. In this context, we have recently demonstrated that knockout of Spry1 (Spry1\n                      <jats:sup>KO<\/jats:sup>\n                      ) in BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM led to cell cycle arrest and apoptosis, repressed cell proliferation in vitro, and reduced tumor growth in vivo. Despite these findings, however, the precise molecular mechanism linking Spry1 to BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM remains to be elucidated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Immunoprecipitation coupled to mass spectrometry was employed to gain insight into Spry1 interactome. Spry1 gene was knocked-out using the CRISPR strategy in the BRAF-mutant cell lines. Transmission electron microscopy was used to assess the relationship between Spry1 expression and mitochondrial morphology. By using in vitro and in vivo models, the effects of Spry1\n                      <jats:sup>KO<\/jats:sup>\n                      were investigated through RNA-sequencing, quantitative real-time PCR, Western blot, and immunofluorescence analyses. The Seahorse XF24 assay allowed real-time measurement of cellular metabolism in our model. Angiogenic potential was assessed through in vitro tube formation assays and in vivo CD31 staining.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Spry1 was mainly located in mitochondria in BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM cells where it interacted with key molecules involved in mitochondrial homeostasis. Spry1 loss resulted in mitochondrial shape alterations and dysfunction, which associated with increased reactive oxygen species production. In agreement, we found that nuclear hypoxia-inducible factor-1 alpha (HIF1\u03b1) protein levels were reduced in Spry1\n                      <jats:sup>KO<\/jats:sup>\n                      clones both in vitro and in vivo along with the expression of its glycolysis related genes. Accordingly, Ingenuity Pathway Analysis identified \u201cHIF1\u03b1 Signaling\u201d as the most significant molecular and cellular function affected by Spry1 silencing, whereas the glycolytic function was significantly impaired in Spry1 depleted BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM cells. In addition, our results indicated that the expression of the vascular endothelial growth factor A was down-regulated following Spry1\n                      <jats:sup>KO<\/jats:sup>\n                      , possibly as a result of mitochondrial dysfunction. Consistently, we observed a substantial impairment of angiogenesis, as assessed by the tube formation assay in vitro and the immunofluorescence staining of CD31 in vivo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Altogether, these findings identify Spry1 as a potential regulator of mitochondrial homeostasis, and uncover a previously unrecognized role for Spry1 in regulating nuclear HIF1\u03b1 expression and angiogenesis in BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>\n                      Spry1\n                      <jats:sup>KO<\/jats:sup>\n                      profoundly impacts on mitochondria homeostasis, while concomitantly impairing HIF1\u03b1-dependent glycolysis and reducing angiogenesis in BRAF-mutant CM cells, thus providing a potential therapeutic target to improve BRAF\n                      <jats:sup>V600<\/jats:sup>\n                      -mutant CM treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03289-8","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T23:10:46Z","timestamp":1739488246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Suppression of Spry1 reduces HIF1\u03b1-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma"],"prefix":"10.1186","volume":"44","author":[{"given":"Barbara","family":"Montico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Giurato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Nassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Memoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Sabatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Comelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bellazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Fejza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Camicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Baboci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Dal Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Covre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula A.","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Steffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sigalotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mongiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Andreuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-8841","authenticated-orcid":false,"given":"Elisabetta","family":"Fratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"2\u20133","key":"3289_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10555-014-9497-1","volume":"33","author":"S Masoumi-Moghaddam","year":"2014","unstructured":"Masoumi-Moghaddam S, Amini A, Morris DL. The developing story of sprouty and cancer. Cancer Metastasis Rev. 2014;33(2\u20133):695\u2013720. https:\/\/doi.org\/10.1007\/s10555-014-9497-1.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"3289_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/carcin\/bgi066","volume":"26","author":"S Bloethner","year":"2005","unstructured":"Bloethner S, Chen B, Hemminki K, M\u00fcller-Berghaus J, Ugurel S, Schadendorf D, et al. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis. 2005;26(7):1224\u201332. https:\/\/doi.org\/10.1093\/carcin\/bgi066.","journal-title":"Carcinogenesis"},{"issue":"3","key":"3289_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1677\/erc.1.01190","volume":"13","author":"S Fritzsche","year":"2006","unstructured":"Fritzsche S, Kenzelmann M, Hoffmann MJ, Muller M, Engers R, Grone HJ, et al. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr Relat Cancer. 2006;13(3):839\u201349. https:\/\/doi.org\/10.1677\/erc.1.01190.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"3289_CR4","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1074\/jbc.M709046200","volume":"283","author":"P Lito","year":"2008","unstructured":"Lito P, Mets BD, Kleff S, O\u2019Reilly S, Maher VM, McCormick JJ. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts. J Biol Chem. 2008;283(4):2002\u20139. https:\/\/doi.org\/10.1074\/jbc.M709046200.","journal-title":"J Biol Chem"},{"issue":"38","key":"3289_CR5","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/onc.2010.264","volume":"29","author":"C Holgren","year":"2010","unstructured":"Holgren C, Dougherty U, Edwin F, Cerasi D, Taylor I, Fichera A, et al. Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty\/c-Met upregulation in human colonic adenocarcinomas. Oncogene. 2010;29(38):5241\u201353. https:\/\/doi.org\/10.1038\/onc.2010.264.","journal-title":"Oncogene"},{"issue":"2","key":"3289_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/0008-5472.can-09-2532","volume":"70","author":"G Schaaf","year":"2010","unstructured":"Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, Versteeg R, et al. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene. Cancer Res. 2010;70(2):762\u201371. https:\/\/doi.org\/10.1158\/0008-5472.can-09-2532.","journal-title":"Cancer Res"},{"issue":"7","key":"3289_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/jcb.24504","volume":"114","author":"XL Jin","year":"2013","unstructured":"Jin XL, Sun QS, Liu F, Yang HW, Liu M, Liu HX, et al. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. J Cell Biochem. 2013;114(7):1625\u201333. https:\/\/doi.org\/10.1002\/jcb.24504.","journal-title":"J Cell Biochem"},{"issue":"4","key":"3289_CR8","first-page":"1531","volume":"5","author":"S Masoumi-Moghaddam","year":"2015","unstructured":"Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL. Sprouty 1 predicts prognosis in human epithelial ovarian cancer. Am J Cancer Res. 2015;5(4):1531\u201341.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"3289_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/onc.2016.244","volume":"36","author":"F Cidre-Aranaz","year":"2017","unstructured":"Cidre-Aranaz F, Grunewald TG, Surdez D, Garcia-Garcia L, Carlos Lazaro J, Kirchner T, et al. EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma. Oncogene. 2017;36(6):766\u201376. https:\/\/doi.org\/10.1038\/onc.2016.244.","journal-title":"Oncogene"},{"issue":"5","key":"3289_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41419-020-2585-y","volume":"11","author":"B Montico","year":"2020","unstructured":"Montico B, Colizzi F, Giurato G, Rizzo A, Salvati A, Baboci L, et al. Loss of Spry1 reduces growth of BRAF(V600)-mutant cutaneous melanoma and improves response to targeted therapy. Cell Death Dis. 2020;11(5):392. https:\/\/doi.org\/10.1038\/s41419-020-2585-y.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3289_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jds.2020.07.013","volume":"16","author":"YY Wang","year":"2021","unstructured":"Wang YY, Wang WC, Su CW, Hsu CW, Yuan SS, Chen YK. Overexpression of sprouty 1 protein in human oral squamous cell carcinogenesis. J Dent Sci. 2021;16(1):21\u20138. https:\/\/doi.org\/10.1016\/j.jds.2020.07.013.","journal-title":"J Dent Sci"},{"key":"3289_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ibneur.2022.07.003","volume":"13","author":"SY Park","year":"2022","unstructured":"Park SY, Jeong HY, Batara DC, Lee SJ, Cho JY, Kim SH. Sprouty 1 is associated with stemness and cancer progression in glioblastoma. IBRO Neurosci Rep. 2022;13:120\u20136. https:\/\/doi.org\/10.1016\/j.ibneur.2022.07.003.","journal-title":"IBRO Neurosci Rep"},{"issue":"1","key":"3289_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/16078454.2021.2010330","volume":"27","author":"G Lv","year":"2022","unstructured":"Lv G, Wang Y, Ji C, Shi C, Li Y. SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia. Hematology. 2022;27(1):1\u201310. https:\/\/doi.org\/10.1080\/16078454.2021.2010330.","journal-title":"Hematology"},{"issue":"4","key":"3289_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s13402-023-00791-z","volume":"46","author":"T Shi","year":"2023","unstructured":"Shi T, Li X, Zheng J, Duan Z, Ooi YY, Gao Y, et al. Increased SPRY1 expression activates NF-\u03baB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis. Cell Oncol (Dordr). 2023;46(4):969\u201385. https:\/\/doi.org\/10.1007\/s13402-023-00791-z.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"3289_CR15","first-page":"2191","volume":"15","author":"J Deng","year":"2023","unstructured":"Deng J, Wu M. COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma. Am J Transl Res. 2023;15(3):2191\u2013206.","journal-title":"Am J Transl Res"},{"key":"3289_CR16","doi-asserted-by":"publisher","unstructured":"He Q, Jing H, Liaw L, Gower L, Vary C, Hua S, et al. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF\/EGFR mediated mesenchymal phenotype. Sci Rep. 2016;6:23216. https:\/\/doi.org\/10.1038\/srep23216. https:\/\/www.nature.com\/articles\/srep23216#supplementary-information.","DOI":"10.1038\/srep23216"},{"issue":"7","key":"3289_CR17","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1158\/0008-5472.Can-06-3312","volume":"67","author":"SM Kumar","year":"2007","unstructured":"Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, et al. Mutant V600E BRAF Increases Hypoxia Inducible Factor-1\u03b1 Expression in Melanoma. Cancer Res. 2007;67(7):3177\u201384. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-3312.","journal-title":"Cancer Res"},{"issue":"5","key":"3289_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/exd.12679","volume":"24","author":"A Marconi","year":"2015","unstructured":"Marconi A, Borroni RG, Truzzi F, Longo C, Pistoni F, Pellacani G, et al. Hypoxia-Inducible Factor-1\u03b1 and CD271 inversely correlate with melanoma invasiveness. Exp Dermatol. 2015;24(5):396\u20138. https:\/\/doi.org\/10.1111\/exd.12679.","journal-title":"Exp Dermatol"},{"issue":"6","key":"3289_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/cmr.0000000000000393","volume":"27","author":"M Mart\u00ednez-Garc\u00eda","year":"2017","unstructured":"Mart\u00ednez-Garc\u00eda M, Riveiro-Falkenbach E, Rodr\u00edguez-Peralto JL, Nagore E, Martorell-Calatayud A, Campos-Rodr\u00edguez F, et al. A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1\u03b1 and VEGF expressions. Melanoma Res. 2017;27(6):558\u201364. https:\/\/doi.org\/10.1097\/cmr.0000000000000393.","journal-title":"Melanoma Res"},{"issue":"5","key":"3289_CR20","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.3390\/ijms24054430","volume":"24","author":"S Jeon","year":"2023","unstructured":"Jeon S, Jeon M, Choi S, Yoo S, Park S, Lee M, et al. Hypoxia in skin cancer: molecular basis and clinical implications. Int J Mol Sci. 2023;24(5):4430.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"3289_CR21","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1111\/febs.16110","volume":"289","author":"V Manuelli","year":"2022","unstructured":"Manuelli V, Pecorari C, Filomeni G, Zito E. Regulation of redox signaling in HIF-1-dependent tumor angiogenesis. FEBS J. 2022;289(18):5413\u201325. https:\/\/doi.org\/10.1111\/febs.16110.","journal-title":"FEBS J"},{"issue":"3","key":"3289_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.002.","journal-title":"Cell Metab."},{"key":"3289_CR23","doi-asserted-by":"publisher","first-page":"111873","DOI":"10.1016\/j.biopha.2021.111873","volume":"141","author":"M Malekan","year":"2021","unstructured":"Malekan M, Ebrahimzadeh MA, Sheida F. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed Pharmacother. 2021;141:111873. https:\/\/doi.org\/10.1016\/j.biopha.2021.111873.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3289_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1476-4598-8-104","volume":"8","author":"CN Mills","year":"2009","unstructured":"Mills CN, Joshi SS, Niles RM. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol Cancer. 2009;8(1):104. https:\/\/doi.org\/10.1186\/1476-4598-8-104.","journal-title":"Mol Cancer"},{"issue":"6","key":"3289_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ejca.2010.01.031","volume":"46","author":"S Kuphal","year":"2010","unstructured":"Kuphal S, Winklmeier A, Warnecke C, Bosserhoff A-K. Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer. 2010;46(6):1159\u201369. https:\/\/doi.org\/10.1016\/j.ejca.2010.01.031.","journal-title":"Eur J Cancer"},{"key":"3289_CR26","doi-asserted-by":"publisher","unstructured":"Huang C, Radi RH, Arbiser JL. Mitochondrial Metabolism in Melanoma. Cells. 2021;10(11). https:\/\/doi.org\/10.3390\/cells10113197.","DOI":"10.3390\/cells10113197"},{"issue":"1","key":"3289_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12967-023-04286-1","volume":"21","author":"Z Luo","year":"2023","unstructured":"Luo Z, Yao J, Wang Z, Xu J. Mitochondria in endothelial cells angiogenesis and function: current understanding and future perspectives. J Transl Med. 2023;21(1):441. https:\/\/doi.org\/10.1186\/s12967-023-04286-1.","journal-title":"J Transl Med"},{"key":"3289_CR28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fonc.2020.00770","volume":"10","author":"MW van Gisbergen","year":"2020","unstructured":"van Gisbergen MW, Offermans K, Voets AM, Lieuwes NG, Biemans R, Hoffmann RF, et al. Mitochondrial dysfunction inhibits hypoxia-induced HIF-1\u03b1 stabilization and expression of its downstream targets. Front Oncol. 2020;10:770. https:\/\/doi.org\/10.3389\/fonc.2020.00770.","journal-title":"Front Oncol"},{"issue":"1","key":"3289_CR29","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41467-020-16312-7","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu B, Ma J, Li J, Wang D, Wang Z, Wang S. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat Commun. 2020;11(1):2549. https:\/\/doi.org\/10.1038\/s41467-020-16312-7.","journal-title":"Nat Commun"},{"key":"3289_CR30","doi-asserted-by":"publisher","first-page":"730604","DOI":"10.3389\/fnmol.2021.730604","volume":"14","author":"MZ Liang","year":"2021","unstructured":"Liang MZ, Ke TL, Chen L. Mitochondrial protein PGAM5 emerges as a new regulator in neurological diseases. Front Mol Neurosci. 2021;14:730604. https:\/\/doi.org\/10.3389\/fnmol.2021.730604.","journal-title":"Front Mol Neurosci"},{"key":"3289_CR31","doi-asserted-by":"publisher","first-page":"102186","DOI":"10.1016\/j.redox.2021.102186","volume":"48","author":"A Zeb","year":"2021","unstructured":"Zeb A, Choubey V, Gupta R, Kuum M, Safiulina D, Vaarmann A, et al. A novel role of KEAP1\/PGAM5 complex: ROS sensor for inducing mitophagy. Redox Biol. 2021;48:102186. https:\/\/doi.org\/10.1016\/j.redox.2021.102186.","journal-title":"Redox Biol"},{"issue":"8","key":"3289_CR32","doi-asserted-by":"publisher","first-page":"112895","DOI":"10.1016\/j.celrep.2023.112895","volume":"42","author":"S Nag","year":"2023","unstructured":"Nag S, Szederkenyi K, Gorbenko O, Tyrrell H, Yip CM, McQuibban GA. PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics. Cell Rep. 2023;42(8):112895. https:\/\/doi.org\/10.1016\/j.celrep.2023.112895.","journal-title":"Cell Rep"},{"issue":"1","key":"3289_CR33","doi-asserted-by":"publisher","first-page":"2162537","DOI":"10.1080\/10641963.2022.2162537","volume":"45","author":"S Li","year":"2023","unstructured":"Li S, Wen P, Zhang D, Li D, Gao Q, Liu H, et al. PGAM5 expression levels in heart failure and protection ROS-induced oxidative stress and ferroptosis by Keap1\/Nrf2. Clin Exp Hypertens. 2023;45(1):2162537. https:\/\/doi.org\/10.1080\/10641963.2022.2162537.","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"3289_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/15548627.2022.2103961","volume":"19","author":"S Chouhan","year":"2023","unstructured":"Chouhan S, Sawant M, Weimholt C, Luo J, Sprung RW, Terrado M, et al. TNK2\/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. Autophagy. 2023;19(3):1000\u201325. https:\/\/doi.org\/10.1080\/15548627.2022.2103961.","journal-title":"Autophagy"},{"key":"3289_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ircmb.2018.05.004","volume":"340","author":"C Cant\u00f3","year":"2018","unstructured":"Cant\u00f3 C. Mitochondrial Dynamics: Shaping Metabolic Adaptation. Int Rev Cell Mol Biol. 2018;340:129\u201367. https:\/\/doi.org\/10.1016\/bs.ircmb.2018.05.004.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"10\u201312","key":"3289_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2023.0268","volume":"39","author":"I Kawano","year":"2023","unstructured":"Kawano I, Bazila B, Je\u017eek P, Dlaskov\u00e1 A. Mitochondrial Dynamics and Cristae Shape Changes During Metabolic Reprogramming. Antioxid Redox Signal. 2023;39(10\u201312):684\u2013707. https:\/\/doi.org\/10.1089\/ars.2023.0268.","journal-title":"Antioxid Redox Signal"},{"key":"3289_CR37","doi-asserted-by":"publisher","unstructured":"Aminzadeh-Gohari S, Weber DD, Catalano L, Feichtinger RG, Kofler B, Lang R. Targeting Mitochondria in Melanoma. Biomolecules. 2020;10(10). https:\/\/doi.org\/10.3390\/biom10101395.","DOI":"10.3390\/biom10101395"},{"key":"3289_CR38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","volume":"6","author":"J Dan Dunn","year":"2015","unstructured":"Dan Dunn J, Alvarez LA, Zhang X, Soldati T. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol. 2015;6:472\u201385. https:\/\/doi.org\/10.1016\/j.redox.2015.09.005.","journal-title":"Redox Biol"},{"issue":"1","key":"3289_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41420-020-00316-9","volume":"6","author":"X Li","year":"2020","unstructured":"Li X, Zhang W, Cao Q, Wang Z, Zhao M, Xu L, et al. Mitochondrial dysfunction in fibrotic diseases. Cell Death Discov. 2020;6(1):80. https:\/\/doi.org\/10.1038\/s41420-020-00316-9.","journal-title":"Cell Death Discov"},{"issue":"11","key":"3289_CR40","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/antiox12111941","volume":"12","author":"SK Bhullar","year":"2023","unstructured":"Bhullar SK, Dhalla NS. Status of mitochondrial oxidative phosphorylation during the development of heart failure. Antioxidants. 2023;12(11):1941.","journal-title":"Antioxidants"},{"issue":"2","key":"3289_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/biom13020353","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Liang L, Matsumoto M, Iwata K, Umemura A, He F. Reactive oxygen species and NRF2 signaling, friends or foes in cancer? Biomolecules. 2023;13(2):353.","journal-title":"Biomolecules"},{"issue":"10","key":"3289_CR42","doi-asserted-by":"publisher","first-page":"e106214","DOI":"10.15252\/embj.2020106214","volume":"40","author":"M Vara-P\u00e9rez","year":"2021","unstructured":"Vara-P\u00e9rez M, Rossi M, Van den Haute C, Maes H, Sassano ML, Venkataramani V, et al. BNIP3 promotes HIF-1\u03b1-driven melanoma growth by curbing intracellular iron homeostasis. EMBO J. 2021;40(10):e106214. https:\/\/doi.org\/10.15252\/embj.2020106214.","journal-title":"EMBO J"},{"issue":"32","key":"3289_CR43","doi-asserted-by":"publisher","first-page":"16787","DOI":"10.1074\/jbc.M116.714139","volume":"291","author":"KC Hicks","year":"2016","unstructured":"Hicks KC, Patel TB. Sprouty2 Protein Regulates Hypoxia-inducible Factor-\u03b1 (HIF\u03b1) Protein Levels and Transcription of HIF\u03b1-responsive Genes*. J Biol Chem. 2016;291(32):16787\u2013801. https:\/\/doi.org\/10.1074\/jbc.M116.714139.","journal-title":"J Biol Chem"},{"issue":"6","key":"3289_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677\u201384. https:\/\/doi.org\/10.1038\/nm0603-677.","journal-title":"Nat Med"},{"issue":"10","key":"3289_CR45","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cancers16101794","volume":"16","author":"G Cazzato","year":"2024","unstructured":"Cazzato G, Ingravallo G, Ribatti D. Angiogenesis still plays a crucial role in human melanoma progression. Cancers (Basel). 2024;16(10):1794.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3289_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12881-019-0767-1","volume":"20","author":"F Cimmino","year":"2019","unstructured":"Cimmino F, Avitabile M, Lasorsa VA, Montella A, Pezone L, Cantalupo S, et al. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia. BMC Med Genet. 2019;20(1):37. https:\/\/doi.org\/10.1186\/s12881-019-0767-1.","journal-title":"BMC Med Genet"},{"key":"3289_CR47","doi-asserted-by":"publisher","unstructured":"Avagliano A, Fiume G, Pelagalli A, Sanit\u00e0 G, Ruocco MR, Montagnani S, et al. Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol. 2020;10(722). https:\/\/doi.org\/10.3389\/fonc.2020.00722.","DOI":"10.3389\/fonc.2020.00722"},{"issue":"38","key":"3289_CR48","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1073\/pnas.1813460115","volume":"115","author":"J Raynor","year":"2018","unstructured":"Raynor J, Chi H. Sprouty branches out to control T cell memory. Proc Natl Acad Sci U S A. 2018;115(38):9339\u201341. https:\/\/doi.org\/10.1073\/pnas.1813460115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3289_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00395-018-0713-y","volume":"114","author":"T Alakoski","year":"2019","unstructured":"Alakoski T, Ulvila J, Yrj\u00f6l\u00e4 R, Vainio L, Magga J, Szabo Z, et al. Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury. Basic Res Cardiol. 2019;114(2):7. https:\/\/doi.org\/10.1007\/s00395-018-0713-y.","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"3289_CR50","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR. Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Bio. 2021;22(5):346\u201366. https:\/\/doi.org\/10.1038\/s41580-020-00322-w.","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"5","key":"3289_CR51","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","volume":"27","author":"T Cascone","year":"2018","unstructured":"Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, et al. Increased tumor glycolysis characterizes immune resistance to adoptive T Cell Therapy. Cell Metab. 2018;27(5):977-87.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.024.","journal-title":"Cell Metab"},{"key":"3289_CR52","doi-asserted-by":"publisher","unstructured":"Cohen IJ, Pareja F, Socci ND, Shen R, Doane AS, Schwartz J, et al. Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.880959.","DOI":"10.3389\/fimmu.2022.880959"},{"issue":"9","key":"3289_CR53","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35(9):1580-96.e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.001.","journal-title":"Cell Metab"},{"key":"3289_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2023.06.015","volume":"206","author":"J Burtscher","year":"2023","unstructured":"Burtscher J, Hohenauer E, Burtscher M, Millet GP, Egg M. Environmental and behavioral regulation of HIF-mitochondria crosstalk. Free Radic Biol Med. 2023;206:63\u201373. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.015.","journal-title":"Free Radic Biol Med"},{"key":"3289_CR55","doi-asserted-by":"publisher","first-page":"1004511","DOI":"10.3389\/fonc.2022.1004511","volume":"12","author":"J Peng","year":"2022","unstructured":"Peng J, Wang T, Yue C, Luo X, Xiao P. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression. Front Oncol. 2022;12:1004511. https:\/\/doi.org\/10.3389\/fonc.2022.1004511.","journal-title":"Front Oncol"},{"issue":"21","key":"3289_CR56","doi-asserted-by":"publisher","first-page":"e98899","DOI":"10.15252\/embj.201798899","volume":"37","author":"M Sugo","year":"2018","unstructured":"Sugo M, Kimura H, Arasaki K, Amemiya T, Hirota N, Dohmae N, et al. Syntaxin 17 regulates the localization and function of PGAM5 in mitochondrial division and mitophagy. EMBO J. 2018;37(21):e98899. https:\/\/doi.org\/10.15252\/embj.201798899.","journal-title":"EMBO J"},{"issue":"2","key":"3289_CR57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze C, Michaudel C, Mackowiak C, Haas DA, Benda C, Hubel P, et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol. 2018;19(2):130\u201340. https:\/\/doi.org\/10.1038\/s41590-017-0013-y.","journal-title":"Nat Immunol"},{"issue":"10","key":"3289_CR58","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/15548627.2024.2360340","volume":"20","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Chen C, Ma Y, Yan X, Lai N, Wang H, et al. PGAM5 interacts with and maintains BNIP3 to license cancer-associated muscle wasting. Autophagy. 2024;20(10):2205\u201320. https:\/\/doi.org\/10.1080\/15548627.2024.2360340.","journal-title":"Autophagy"},{"issue":"3","key":"3289_CR59","doi-asserted-by":"publisher","first-page":"e1127-e","DOI":"10.1038\/cddis.2014.94","volume":"5","author":"H Maes","year":"2014","unstructured":"Maes H, Van Eygen S, Krysko DV, Vandenabeele P, Nys K, Rillaerts K, et al. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton. Cell Death Dis. 2014;5(3):e1127-e. https:\/\/doi.org\/10.1038\/cddis.2014.94.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3289_CR60","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1365-2133.2010.10200.x","volume":"164","author":"F Ruffini","year":"2011","unstructured":"Ruffini F, Failla CM, Orecchia A, Bani MR, Dorio AS, Fortes C, et al. Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression. Br J Dermatol. 2011;164(5):1061\u201370. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10200.x.","journal-title":"Br J Dermatol"},{"key":"3289_CR61","doi-asserted-by":"crossref","unstructured":"McMurtry MS. Angiogenesis, Arteriogenesis, and Mitochondrial Dysfunction. In: Jugdutt BI, Dhalla NS, editors. Cardiac Remodeling: Molecular Mechanisms. New York, NY: Springer New York; 2013. p. 255\u201372.","DOI":"10.1007\/978-1-4614-5930-9_15"},{"issue":"5","key":"3289_CR62","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.18632\/oncotarget.6405","volume":"7","author":"HD Um","year":"2016","unstructured":"Um HD. Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species. Oncotarget. 2016;7(5):5193\u2013203. https:\/\/doi.org\/10.18632\/oncotarget.6405.","journal-title":"Oncotarget"},{"issue":"4","key":"3289_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.urolonc.2009.04.009","volume":"29","author":"S Anai","year":"2011","unstructured":"Anai S, Sakamoto N, Sakai Y, Tanaka M, Porvasnik S, Urbanek C, et al. Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer. Urol Oncol. 2011;29(4):421\u20139. https:\/\/doi.org\/10.1016\/j.urolonc.2009.04.009.","journal-title":"Urol Oncol"},{"key":"3289_CR64","doi-asserted-by":"publisher","unstructured":"Dissanayaka WL, Han Y, Zhang L, Zou T, Zhang C. Bcl-2 Overexpression and Hypoxia Synergistically Enhance Angiogenic Properties of Dental Pulp Stem Cells. Int J Mol Sci. 2020;21(17). https:\/\/doi.org\/10.3390\/ijms21176159.","DOI":"10.3390\/ijms21176159"},{"key":"3289_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.matbio.2015.04.004","volume":"44\u201346","author":"EI Deryugina","year":"2015","unstructured":"Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 2015;44\u201346:94\u2013112. https:\/\/doi.org\/10.1016\/j.matbio.2015.04.004.","journal-title":"Matrix Biol"},{"issue":"1","key":"3289_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52\u201367. https:\/\/doi.org\/10.1016\/j.cell.2010.03.015.","journal-title":"Cell"},{"issue":"1","key":"3289_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/cvr\/cvt060","volume":"99","author":"C Fang","year":"2013","unstructured":"Fang C, Wen G, Zhang L, Lin L, Moore A, Wu S, et al. An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovasc Res. 2013;99(1):146\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvt060.","journal-title":"Cardiovasc Res"},{"key":"3289_CR68","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Arg\u00e1ez V, Lara-Riegos J, et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 2019;9:1370. https:\/\/doi.org\/10.3389\/fonc.2019.01370.","journal-title":"Front Oncol"},{"issue":"10","key":"3289_CR69","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.neo.2020.08.004","volume":"22","author":"JS Frieling","year":"2020","unstructured":"Frieling JS, Li T, Tauro M, Lynch CC. Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis. Neoplasia (New York, NY). 2020;22(10):511\u201321. https:\/\/doi.org\/10.1016\/j.neo.2020.08.004.","journal-title":"Neoplasia (New York, NY)"},{"key":"3289_CR70","doi-asserted-by":"publisher","unstructured":"Fejza A, Carobolante G, Poletto E, Camicia L, Schinello G, Di Siena E, et al. The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1270981.","DOI":"10.3389\/fimmu.2023.1270981"},{"issue":"14","key":"3289_CR71","first-page":"3343","volume":"53","author":"M Altomonte","year":"1993","unstructured":"Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, et al. Differential expression of cell adhesion molecules CD54\/CD11a and CD58\/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993;53(14):3343\u20138.","journal-title":"Cancer Res"},{"issue":"11","key":"3289_CR72","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/jci107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745\u201356. https:\/\/doi.org\/10.1172\/jci107470.","journal-title":"J Clin Invest."},{"key":"3289_CR73","doi-asserted-by":"publisher","unstructured":"Tremi I, Havaki S, Georgitsopoulou S, Lagopati N, Georgakilas V, Gorgoulis VG, et al. A Guide for Using Transmission Electron Microscopy for Studying the Radiosensitizing Effects of Gold Nanoparticles In Vitro. Nanomaterials (Basel, Switzerland). 2021;11(4). https:\/\/doi.org\/10.3390\/nano11040859.","DOI":"10.3390\/nano11040859"},{"issue":"D1","key":"3289_CR74","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352. https:\/\/doi.org\/10.1093\/nar\/gkab1038.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1186\/s13046-026-03800-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03289-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:37:28Z","timestamp":1787290648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03289-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03289-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The authors found errors in Fig. 1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-026-03800-9","URL":"https:\/\/doi.org\/10.1186\/s13046-026-03800-9","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the preclinical studies were approved by the Internal Review Board of the Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano, Italy (IRB number 07-2017) and the Italian Ministry of Health (no. 788\/2015\/PR).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors agree to publish this paper.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}